Two Japanese firms to buy 86% stake in Eu Yan Sang

Eu Yan Sang operates over 170 retail outlets in China, Hong Kong, Macau, Malaysia and Singapore. — The Straits Times

SINGAPORE: Two Japanese firms are providing and outlay of US$594mil to buy out local traditional Chinese medicine maker Eu Yan Sang.

Japanese trading house Mitsui & Co announced on April 4 that a special purpose entity it has set up with Rohto Pharmaceutical will buy around 86% of Eu Yan Sang from Righteous Crane Holding.